Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-055440
Filing Date
2007-03-15
Accepted
2007-03-15 13:31:11
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 849449
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 4104
3 CERTIFICATION dex311.htm EX-31.1 10369
4 CERTIFICATION dex312.htm EX-31.2 10452
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION dex321.htm EX-32.1 3547
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION dex322.htm EX-32.2 3508
7 GRAPHIC g87555g24e57.jpg GRAPHIC 12207
8 GRAPHIC g87555g52j14.jpg GRAPHIC 71367
  Complete submission text file 0001193125-07-055440.txt   998337
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23265 | Film No.: 07695939
SIC: 2834 Pharmaceutical Preparations